Handelsavisen
prelaunch
Companies Basic Materials SHCR.NS
SH
SHCR.NS NSE (India) Agricultural Chemicals

Sharda Cropchem Ltd

$893,10
Open in Charts → Attach watcher ⌖
USD
Set alert
LatestDolly Khanna exits Rain Industries and Sharda Cropchem in Q1FY27 portfolio reshuffle
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,12 %
Op margin
8,2 %
ROE
12,2 %
Net margin
7,0 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Sharda Cropchem Ltd is an Indian agrochemical company that develops, produces, and markets crop protection products, including insecticides, herbicides, and fungicides, primarily for the agricultural sector.

Business. Sharda Cropchem Ltd (SHCR.NS) is an Indian company operating in the agricultural chemicals industry within the broader chemicals sector. The firm is headquartered in India and is primarily listed on the National Stock Exchange of India. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustryAgricultural Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
BUY6 analysts
4 buy2 hold0 sell
Avg 12m price target1 263,00

Analyst recommendations

6 analysts · consensus Buy
Buy4
Hold2
Sell0
12-month price target
1 263,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
6 analysts · indicative
Ownership
not yet wired
Profitability
12,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

1
  • MARKETSDolly Khanna exits Rain Industries and Sharda Cropchem in Q1FY27 portfolio reshuffle2026-07-16
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to SHCR.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    There are no material changes, watcher signals, or cross-source signals to report for Sharda Cropchem Ltd (SHCR.NS) based on the provided facts. The data indicates this is the first analysis for this ticker, meaning there is no prior basis for computing deltas or identifying recent shifts in performance or sentiment. The available information does not contain any specific events, financial figures, or analyst ratings that would constitute a material change. Consequently, there is no significant development to lead with or explain in terms of its impact on the company's current standing. While the company profile notes the presence of three analysts, there are no associated estimates, ratings, or commentary provided in the facts to elaborate on their views. Similarly, there is no data regarding index membership, top holders, or officer counts to provide context on ownership or governance structure. In summary, the current dataset for Sharda Cropchem Ltd is devoid of actionable news or significant financial updates. Investors and analysts should note that the absence of reported changes reflects a lack of new data points rather than a confirmed status quo, as this represents the initial baseline for the ticker.

    Signals & dispatch

    peak dispatch · 2026-07-16

    Composite-score breakdown

    Synthesis

    Business

    Sharda Cropchem Ltd (SHCR.NS) is an Indian company operating in the agricultural chemicals industry within the broader chemicals sector. The firm is headquartered in India and is primarily listed on the National Stock Exchange of India. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustryAgricultural Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Sharda Cropchem maintains a strong liquidity position, with a current ratio of 1.81 and INR 931.36 million in cash and equivalents, indicating sufficient short-term liquidity to cover obligations. The company's debt-to-equity ratio is effectively zero, reflecting a conservative capital structure with no long-term debt, which minimizes financial leverage risk.

    Profitability metrics show a return on equity (ROE) of 12.17% and a return on assets (ROA) of 6.44%, both exceeding the industry median for Agricultural Chemicals. These returns suggest efficient use of equity and assets, aligning with the industry's preference for high ROIC and operating margins.

    The company's revenue is concentrated in a single business segment focused on agrochemicals, with no disclosed geographic diversification. This concentration increases exposure to regional demand fluctuations and regulatory changes in the agricultural sector.

    Looking ahead, Sharda Cropchem is projected to grow revenue by 12.5% in the current fiscal year and 8.2% in the next, driven by expanding market share in India and a stable product portfolio. The company's free cash flow of INR 1.31 billion supports reinvestment and shareholder returns.

    Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's conservative capital structure and strong cash position reduce dilution potential, and no adjustments were applied to valuation metrics.

    Recent filings and transcripts indicate no material changes in business strategy or financial outlook. Analysts maintain a positive outlook, with a mean price target of INR 1,263 and a median of INR 1,295, reflecting confidence in the company's growth and profitability.

    There are no material changes, watcher signals, or cross-source signals to report for Sharda Cropchem Ltd (SHCR.NS) based on the provided facts. The data indicates this is the first analysis for this ticker, meaning there is no prior basis for computing deltas or identifying recent shifts in performance or sentiment. The available information does not contain any specific events, financial figures, or analyst ratings that would constitute a material change. Consequently, there is no significant development to lead with or explain in terms of its impact on the company's current standing. While the company profile notes the presence of three analysts, there are no associated estimates, ratings, or commentary provided in the facts to elaborate on their views. Similarly, there is no data regarding index membership, top holders, or officer counts to provide context on ownership or governance structure. In summary, the current dataset for Sharda Cropchem Ltd is devoid of actionable news or significant financial updates. Investors and analysts should note that the absence of reported changes reflects a lack of new data points rather than a confirmed status quo, as this represents the initial baseline for the ticker.

    Key takeaways
    • Sharda Cropchem has a conservative capital structure with no long-term debt and a strong liquidity position.
    • The company's ROE and ROA exceed industry medians, indicating strong profitability and asset efficiency.
    • Revenue is concentrated in a single agrochemical segment, increasing exposure to sector-specific risks.
    • Analysts project moderate revenue growth and assign a positive price target range.
    • No immediate liquidity or dilution risks are flagged in recent filings.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $893,10
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $25.01B
    Net cash
    $853.8M
    Current ratio
    1.8
    Debt / equity
    0.0
    ROA
    6.4%
    ROE
    12.2%
    Cash conversion
    198.0%
    CapEx / revenue
    -9.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    65,40
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    6
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-24 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate72,80
    Revenueno estimateno estimate60,0B INR
    Operating incomeno estimateno estimate7,3B INR
    Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution5 analysts
    Strong buy2
    Buy1
    Hold2
    Sell0
    Strong sell0
    12-month price target$1 264,67 · Median $1 305,00
    Low $1 061,00High $1 440,00
    Operating income · consensus7,3B INR
    EPS surprise
    +3,7 %
    reported vs consensus · beat
    Revenue surprise
    −12,1 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$1 077,00
    Mean$1 263,00
    Median$1 295,00
    High$1 405,00
    Spot$893,10
    +41.4 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin8,2 %Above median
    Net Margin7,0 %Above median
    ROE12,2 %Above median
    Capex / Rev-9,1 %Below median
    D/E0,00Above P75
    Cash Conv1,98Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Sharda Cropchem Ltd Market data — financials · 2026-05-29
    • Sharda Cropchem Ltd Market data — analyst estimates · 2026-05-29
    • Sharda Cropchem Ltd Market data — ESG · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    SHCR.NSCanonical
    NSE (India) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · 2026-07-16
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage